What one share of Adial Pharmaceuticals holds
We have devoted the vast majority of our resources to development efforts relating to AD04, including preparation for and conducting clinical trials, providing general and administrative support for these operations and protecting our intellectual property.
Adial Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$29.08 |
|---|---|
| Cash and investments | $10.93 |
| Book value | −$14.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$545.00 | — | — | — | $430.43 |
| 2020 | — | −$546.26 | — | — | — | $173.09 |
| 2021 | — | −$653.06 | $2.17 | −$403.94 | — | $104.66 |
| 2022 | — | −$317.81 | — | — | — | $76.73 |
| 2023 | — | −$89.90 | — | — | — | $61.37 |
| 2024 | — | −$68.01 | — | — | — | $15.72 |
| 2025 | — | −$11.93 | — | — | — | $4.75 |
Common questions about Adial Pharmaceuticals
How much does one share of Adial Pharmaceuticals earn?
Over the last 12 months, Adial Pharmaceuticals lost $29.08 for each share.
Does Adial Pharmaceuticals pay a dividend?
Adial Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Adial Pharmaceuticals’s book value per share?
Adial Pharmaceuticals’s book value is negative (−$14.61 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Adial Pharmaceuticals have?
Each share of Adial Pharmaceuticals has $10.93 of cash and investments, as of June 30, 2026.
Has Adial Pharmaceuticals bought back shares?
Adial Pharmaceuticals’s share count rose about 4142% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.